Related Experiment Video
Updated: Sep 22, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Multidisciplinary Effort to Drive Precision-Medicine for the Future
Dewei Kong1,2,3, Haojie Yu4,5, Xueling Sim5,6
1Stem Cells and Diabetes Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
Precision medicine (PM) is transforming healthcare, with Singapore
Area of Science:
- Genomics
- Translational Research
- Bioinformatics
Background:
- The global shift towards precision medicine (PM) necessitates robust data infrastructure.
- Singapore's National Precision Medicine (NPM) program (est. 2017) is advancing to create a large genomic database for Asians.
- The National University of Singapore (NUS) launched a PM translational research program (TRP) in 2021.
Purpose of the Study:
- To consolidate multidisciplinary expertise for PM initiatives.
- To identify and validate novel therapeutic targets.
- To establish frameworks for data handling and interpretation in PM.
Main Methods:
- Leveraging omics-based technologies.
- Developing collaborative, multidisciplinary research projects.
- Implementing appropriate data collection, processing, and interpretation protocols.
Main Results:
- Singapore is building a significant genomic database for Asian populations.
- NUS is fostering cross-disciplinary collaboration for PM.
- Progress is being made in addressing challenges in PM data management.
Conclusions:
- The era of precision medicine requires advanced data strategies.
- Continuous technological development and regulatory improvements are key to overcoming PM challenges.
- Successful implementation of PM will enable precise disease prediction, diagnosis, treatment, and prevention.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
07:46Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Microorganisms in Medicine and Therapeutics